Item 8.01. Other Events.
On April 19, 2021, United Therapeutics Corporation issued a press release
announcing the submission of the Tyvaso DPI™ New Drug Application to the U.S.
Food and Drug Administration. The press release is attached as Exhibit 99.1 and
is incorporated herein by reference.
TYVASO DPI is a trademark of United Therapeutics Corporation.
Item 9.01. Exhibits
(d) Exhibits
Exhibit No. Description of Exhibit
99.1 Press release dated April 19, 2021
104 The cover page from this Current Report on Form 8-K, formatted in
Inline XBRL
2
© Edgar Online, source Glimpses